Surgery · Hepatobiliary Surgery (Liver Tumors, Gall Bladder, Bile Duct, Pancreas)

IPMN (intraductal papillary mucinous neoplasm) of the pancreas is classified by duct involvement. Which subtype carries the highest risk of harboring invasive carcinoma and warrants resection in fit patients?

  • A Branch duct IPMN <1 cm without worrisome features
  • B Mixed-type IPMN without mural nodules or pancreatitis
  • C Main duct IPMN (dilation ≥5 mm) — absolute indication for resection in fit patients
  • D Branch duct IPMN 2–3 cm with stable appearance over 2 years
Correct answer: C. Main duct IPMN (dilation ≥5 mm) — absolute indication for resection in fit patients

Explanation

Main duct IPMN (MD-IPMN, main pancreatic duct ≥5 mm without other cause) carries a 40–70% rate of malignancy (high-grade dysplasia or invasive carcinoma) and is an absolute indication for surgical resection in fit patients per IAP (Fukuoka/Kyoto) guidelines 2017. Branch duct IPMNs have a much lower risk (~25%) but require resection if 'high-risk stigmata' (enhancing mural nodule, main duct ≥10 mm, obstructive jaundice) are present. Small branch duct IPMNs without worrisome features undergo surveillance.

Reference: Bailey & Love's Short Practice of Surgery, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hepatobiliary Surgery (Liver Tumors, Gall Bladder, Bile Duct, Pancreas) MCQs

See all Hepatobiliary Surgery (Liver Tumors, Gall Bladder, Bile Duct, Pancreas) MCQs →